CYP3A4*20, CYP3A4*22, CYP2C8*3 and SLCO1B1 as genetic biomarkers to predict peripheral neuropathy induced by paclitaxel and docetaxel: A systematic review

Context: Cancer is a global health problem with a growing incidence year after year, and it is projected that by 2040, there will be more than 2.4 million cases in Latin America and the Caribbean, being the second cause of death in these countries. The variability of serum levels, efficacy and safet...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Angel T. Alvarado, Mario Bolarte-Arteaga, Mario Pineda-Pérez, César Li-Amenero, Haydee Chávez, María R. Bendezú, Jorge A. García, Juan J. Palomino-Jhong, Carmela Ferreyra-Paredes, Elizabeth J. Melgar-Merino, Doris Laos-Anchante, Pompeyo A. Cuba-Garcia, Patricia Castillo-Romero, Paulina Eliades Yarasca-Carlos, José Santiago Almeida-Galindo, Berta Loja-Herrera, Ricardo Pariona-Llanos
Formato:	Artigo
Idioma:	Inglês
Publicado em:	GarVal Editorial Ltda. 2025-05-01
coleção:	Journal of Pharmacy & Pharmacognosy Research
Assuntos:	cyp3a4 cyp2c8 slco1b1 paclitaxel neuropathy
Acesso em linha:	https://jppres.com/jppres/pdf/vol13/jppres24.2125_13.3.955.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!